Taiwan's Medigen Vaccine Biologics Corp. will provide a free polymerase chain reaction (PCR) testing service to recipients of its protein-based COVID-19 vaccine who wish to travel to Japan until the end of 2022, the company announced Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
NZ parliamentarians call for more cooperation on energy with Taiwan
04/16/2024 11:46 PM - Society
Number of flu cases falls, severe cases reach 26 over past week: CDC
04/16/2024 10:43 PM - Society
Taiwan reports 139,848 cases of diarrhea last week: Taiwan CDC
04/16/2024 10:09 PM - Society
Pingtung to implement conservation fee for Liuqiu Island intertidal zones
04/16/2024 09:53 PM - Science & Tech
Mobile air defense system makes successful debut at Pingtung drill: Source
04/16/2024 09:26 PM